HYGIEIA
Company

Last deal

$22.M

Amount

Series B

Stage

02.05.2023

Date

14

all rounds

$52.3M

Total amount

General

About Company
Heggieia's d-Nav® Insulin Management System helps people with Type 2 diabetes use insulin safely and effectively.

Industry

Sector :

Subsector :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Developed by two University of Michigan researchers, the d-Nav® Insulin Management System guides users to adjust their insulin doses based on changing blood glucose patterns every few days, resulting in improved glycemic control. Studies have shown that 90 percent of users achieve lower A1c levels within three months, leading to better health outcomes, reduced complications, less time spent at the physician's office, and lower disease management costs. The system has been peer-reviewed and published in leading medical journals. Hygieia, headquartered in Livonia, Michigan, is focused on enhancing and simplifying insulin therapy for diabetes patients.
Contacts

Phone number

Social url